Zobrazeno 1 - 10
of 16
pro vyhledávání: '"A M, Esaian"'
Autor:
G. P. Arutiunov, E. I. Tarlovskaia, N. A. Koziolova, M. V. Boldina, M. M. Batiushin, A. S. Ametov, A. G. Arutiunov, A. S. Belevskii, G. R. Galstian, N. I. Grigor’eva, G. A. Dzhunusbekova, A. M. Esaian, S. V. Mal’chikova, N. P. Mit’kovskaia, A. M. Mkrtumian, I. A. Orlova, M. M. Petrova, A. P. Rebrov, D. I. Ruzanov, V. V. Salukhov, A. S. Sisakian, V. V. Skibitskii, A. B. Sugraliev, I. V. Fomin, I. S. Khalimov, A. I. Chesnikova, I. I. Shaposhnik, M. V. Shestakova
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 108-124 (2020)
The agreement of experts of the Eurasian Association of Therapists (EAT) discusses pathogenesis and treatment of COVID-19. Modern data on the characteristics of cardiovascular, kidney, respiratory damage in SARS-infected CoV-2 are presented. The tact
Externí odkaz:
https://doaj.org/article/0fe55de9f9164f0693832f57f7830814
Autor:
E I Tarlovskaia, N. A. Koziolova, V V Skibitskii, Marina Vladimirovna Shestakova, A G Arutiunov, A P Rebrov, A M Mkrtumian, Ia A Orlova, V V Salukhov, A M Esaian, M M Batiushin, M. V. Boldina, A I Chesnikova, N P Mit'kovskaia, I. V. Fomin, A S Belevskii, A S Ametov, M M Petrova, I I Shaposhnik, G P Arutiunov, A B Sugraliev, G R Galstian, N I Grigor'eva, G A Dzhunusbekova, I S Khalimov, D I Ruzanov, S V Mal'chikova, A S Sisakian
Publikováno v:
Терапевтический архив, Vol 92, Iss 9, Pp 108-124 (2020)
The agreement of experts of the Eurasian Association of Therapists (EAT) discusses pathogenesis and treatment of COVID-19. Modern data on the characteristics of cardiovascular, kidney, respiratory damage in SARS-infected CoV-2 are presented. The tact
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 25(3)
The aim of the study was to investigate the effectiveness of long application of the combined therapy by cytostatics and steroid hormones for patients with morphologically proved membranoproliferative glomerulonephritis depending on age. 51 patients
Publikováno v:
Advances in gerontology = Uspekhi gerontologii. 25(2)
The aim of the study was to investigate the effectiveness of combined long-term therapy by cytostatics and steroid hormones in older patients with membranoproliferative glomerulonephritis to halt renal failure progression. 27 patients older than 60 y
Autor:
Ivan Kayukov, I. E. Sevastyanova, A. M. Esaian, Marina Parastaeva, Olga Beresneva, L. V. Kotenko, A. Zh. Karabayeva
Publikováno v:
Bulletin of experimental biology and medicine. 145(6)
Chronic renal failure was modeled in rats by partial nephrectomy. Blood pressure, heart rate, concentrations of aldosterone, urea, creatinine, electrolytes, and protein, index of hypertrophy of visceral organs, and 24-h diuresis were evaluated. In ra
Publikováno v:
Klinicheskaia meditsina. 85(12)
The work reflects modern concepts of the pathogenesis of myocardial and vascular remodelling in a chronic renal disease. Types of changes in left ventricular geometry and the condition of the diastolic function in patients at pre-dialysis stage of a
Publikováno v:
Terapevticheskii arkhiv. 74(6)
To study changes in renal function in response to protein loads in patients with chronic glomerulonephritis (CGN) who have normal renal function and initial uremia.63 CGN patients were divided into two groups: 40 patients of group 1 (17 males, 23 fem
Publikováno v:
Patologicheskaia fiziologiia i eksperimental'naia terapiia. (2)
The important role of increasing plasma urea levels in renal failure progression was shown in Wistar rats with experimental uremia induced by subtotal nephrectomy. Renal structural lesions and dysfunction were the same as in rats fed a high-protein d
Publikováno v:
Urologiia i nefrologiia. (2)
Bicycle ergometry (BE) up to submaximal heart rate provoked moderate metabolic acidosis in 52 patients with chronic pyelonephritis (CP) in preuremic stage. Similar changes in acid-base balance following BE were noted in 14 patients with chronic glome
Publikováno v:
Terapevticheskii arkhiv. 67(6)
By a reciprocal of creatininemia the rate of chronic renal failure progression (CRF) was assessed in 14 patients with nephropathy on enalapril treatment. The day dose ranged from 2.5 to 15 mg. In patients with serum creatinin levels from 0.24 to 0.41